Similarities between dogs and humans |
Physiological age of onset and clinical symptoms |
Pathologically high grade, heterogenous cancer |
Molecular subtypes (e.g., luminal, basal) |
Epigenetic features |
Shared molecular targets (e.g., EGFR, CDKN2B, PIK3CA, BRCA2, and NFkB) |
Local cancer invasion into the bladder wall |
Distant cancer metastases in ≥50% of subjects |
Response to chemotherapy (e.g., cisplatin, carboplatin, and vinblastine) |
Differences between dogs and humans |
Sex differences (male : female ratio 2 : 1 in humans, 0.5 : 1 in dogs; although most dogs studied had been spayed or neutered) |
Tumor location in bladder (more often trigonal in dogs; more variable in humans) |
Dog tumors possess dog homologue of BRAF V600E mutation common in human melanoma (human InvUC has other variants in MAPK signaling) |